Micreos

MICREOS is a Swiss-based biotechnology company pioneering a new class of precision biologics to selectively eliminate disease-driving pathogens. Its engineered endolysin platform starts in atopic dermatitis, with endolysins designed to eliminate Staphylococcus aureus while preserving the healthy skin microbiome.